Wundrsight

Private

BangaloreHealthcare & Life Scienceshttp://www.wundrsight.com

Last Round

Seed

Sep 12, 2024

Total Funding Raised

$400,000

Company Overview

Wundrsight is a digital therapeutics company that provides a VR-powered digital therapeutics (DTx) platform for mental health.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, AR/VR Experiences, Medical AI, Telemedicine

Business Model

B2B

Customer Profile

Subscription SaaS, Hardware + Subscription, Government Contracts

AI Layer

Application

Keywords

digital therapeuticsVR therapyDTxmental healthcare platformdigital mental healthVR exposure therapyclinician-led therapybehavioral health platformsubstance use disorder treatmentanxiety and phobia treatmentOCD treatmentimmersive therapiesADHD and autism therapyAI-powered mental healthmedication-free therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Wundrsight Comparables

Compare Wundrsight with similar companies based on industry and business-model similarity.

Wundrsight comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Wundrsight Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Sep 12, 2024

View all Funding Rounds

Key People

Founding team and executive leadership

Nishtha Budhiraja ️‍

Chief Medical Officer, Principal Psychologist And Co-Founder At Wundrsight Health, Chief People Officer

Founding Team

Raunak Swarnkar

Co-Founder & CEO

Founding Team

Wundrsight Investors

Notable investors and investment history

Wundrsight investors
Investor	Rounds
Inflection Point Ventures	Seed
DLabs at Indian School of Business	Seed
Social Alpha	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 22, 2026
Monthly visitors grew 413% MoM, from 99 to 508.
May 5, 2025
Grew 23% QoQ, from 13 to 16 employees.

View all signals

Wundrsight Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Wundrsight Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Wundrsight's valuation, stock price, and market status.

Firmographic Details

HeadquartersBangalore

Employee Range12

Year Founded2022

Last FundingSep 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.